Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Van der Veken

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|April 28, 2005
The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidasesK Augustyns, P Van der Veken, K Senten, et al.
B-ENT|February 26, 2013
Craniofacial embryology and postnatal development of relevant parts of the upper respiratory systemS Halewyck, S Louryan, P Van Der Veken, et al.
B-ENT|March 21, 2018
Hearing prevention experienceF De Boodt, P Van der Veken, S Esertepe, et al.
Clinical Nuclear Medicine|May 1, 1989
Imaging of sinusitis in Wegener's granulomatosisF De Geeter, L Van Maele, P Van der Veken, et al.
Current Medicinal Chemistry|May 25, 2010
Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?M Berg, P Van der Veken, A Goeminne, et al.
B-ENT|February 21, 2018
Introduction to the annual report 2016: a joint venture in the field of Acute ENTJ B Watelet, J De Brouwer, P Van der Veken, et al.
Journal of Medicinal Chemistry|April 30, 2004
Development of irreversible diphenyl phosphonate inhibitors for urokinase plasminogen activatorJ Joossens, P Van der Veken, A-M Lambeir, et al.
Protein Engineering, Design & Selection : PEDS|January 8, 2017
Ligand-induced conformational changes in prolyl oligopeptidase: a kinetic approachR Van Elzen, E Schoenmakers, I Brandt, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2015
Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarctionD Leenaerts, J M Bosmans, P van der Veken, et al.
Acta Oto-Rhino-Laryngologica Belgica|January 1, 1989
[CAT-scan study of the prevalence of sinus disorders and anatomical variations in 196 children]P Van der Veken, P A Clement, T Buisseret, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|April 28, 2005
The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidasesK Augustyns, P Van der Veken, K Senten, et al.
B-ENT|February 26, 2013
Craniofacial embryology and postnatal development of relevant parts of the upper respiratory systemS Halewyck, S Louryan, P Van Der Veken, et al.
B-ENT|March 21, 2018
Hearing prevention experienceF De Boodt, P Van der Veken, S Esertepe, et al.
Clinical Nuclear Medicine|May 1, 1989
Imaging of sinusitis in Wegener's granulomatosisF De Geeter, L Van Maele, P Van der Veken, et al.
Current Medicinal Chemistry|May 25, 2010
Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?M Berg, P Van der Veken, A Goeminne, et al.
B-ENT|February 21, 2018
Introduction to the annual report 2016: a joint venture in the field of Acute ENTJ B Watelet, J De Brouwer, P Van der Veken, et al.
Journal of Medicinal Chemistry|April 30, 2004
Development of irreversible diphenyl phosphonate inhibitors for urokinase plasminogen activatorJ Joossens, P Van der Veken, A-M Lambeir, et al.
Protein Engineering, Design & Selection : PEDS|January 8, 2017
Ligand-induced conformational changes in prolyl oligopeptidase: a kinetic approachR Van Elzen, E Schoenmakers, I Brandt, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2015
Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarctionD Leenaerts, J M Bosmans, P van der Veken, et al.
Acta Oto-Rhino-Laryngologica Belgica|January 1, 1989
[CAT-scan study of the prevalence of sinus disorders and anatomical variations in 196 children]P Van der Veken, P A Clement, T Buisseret, et al.
Pageof 2